Delivery Order SPE2DB22D3501-SPE2DB24FWM05

Award Date 7/31/24
Potential Completion Date 8/1/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The $7,662.75 firm fixed-price contract is for the delivery of epinephrine 0.3 mg auto-injectors. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $2,067.08 firm fixed price award is for the supply of 4,565,215,508 units of Epinephrine 0.3 mg auto-injectors. The contract has an ultimate completion date of July 22, 2024. Amerisourcebergen, through its Corporate Office division, has been a significant provider of...
This is a delivery order award under an Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,329.88 firm fixed-price delivery order is for the supply of epinephrine 0.3 mg auto-injectors. The award has an ultimate completion date of August 2, 2024. Amerisourcebergen holds a significant IDC with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025,...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a delivery order valued at $2,670.29 to provide Epinephrine 0.15 mg auto-injectors. The award was made by the Defense Logistics Agency (DLA), a major Defense Department agency, and has a performance period through July 15, 2024. Amerisourcebergen is a large pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to supply a wide range...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of epinephrine 0.3 mg auto-injectors. The $1,150.20 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical to support the Department of Defense (DoD). Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of epinephrine 0.15 mg auto-injectors. The award, valued at $5,477.42, has a completion date of January 17, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) for the provision of 4,564,702,555 epinephrine 0.3 mg auto-injectors. The $2,607.12 firm fixed-price contract has a completion date of May 24, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of epinephrine 0.3 mg auto-injector devices. The $1,794.36 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $2,691.54 award is for the delivery of Epinephrine 0.3 mg auto-injectors in support of military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,840,504 units of the Epinephrine 0.3 mg auto-injector product. The $2,691.54 firm-fixed-price delivery order was awarded on June 7, 2024 by the Defense Logistics Agency (DLA) and has a completion date of June 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWM05
    Delivery Order

This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office Division, worth $2,581.24, for the supply of epinephrine 0.3 mg auto-injectors. The contract is a firm fixed-price delivery order placed under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 through December 2025. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of medical commodities to various federal agencies and healthcare programs, including the military and veterans' facilities. This particular award does not have a set-aside designation and is scheduled for completion by August 1, 2024.

Generated 10/30/24, 9:46 AM